Timing of PCR and antibody testing in patients with COVID-19–associated dermatologic manifestations - 11/01/21
Doi : 10.1016/j.jaad.2020.09.007
Esther E. Freeman, MD, PhD a, b, ⁎ 
, Devon E. McMahon, BA a, George J. Hruza, MD, MBA c, Jules B. Lipoff, MD d, Lars E. French, MD e, Lindy P. Fox, MD f, Marlys S. Fassett, MD, PhD f, g
, Devon E. McMahon, BA a, George J. Hruza, MD, MBA c, Jules B. Lipoff, MD d, Lars E. French, MD e, Lindy P. Fox, MD f, Marlys S. Fassett, MD, PhD f, g a Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston
b Medical Practice Evaluation Center, Mongan Institute, Massachusetts General Hospital, Boston
c Department of Dermatology, St. Louis University, Missouri
d Department of Dermatology, University of Pennsylvania, Philadelphia
e Department of Dermatology, University Hospital, Munich University of Ludwig Maximilian, Germany
f Department of Dermatology, University of California–San Francisco
g Department of Immunology and Microbiology, University of California–San Francisco
∗Correspondence to: Esther E. Freeman, MD, PhD, Department of Dermatology, Massachusetts General Hospital, 55 Fruit St, Boston, MA 02114Department of DermatologyMassachusetts General Hospital55 Fruit StBostonMA02114
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
| Funding sources: None. |
|
| Conflicts of interest: Drs Freeman, Hruza, Lipoff, and Fox are part of the American Academy of Dermatology COVID-19 Ad Hoc Task Force. Dr French is the President of the International League of Dermatologic Societies. Dr Freeman is an author of COVID-19 dermatology for UpToDate. Dr Fassett and Author McMahon have no conflicts of interest to declare. |
|
| IRB approval status: The registry was reviewed by the Partners Healthcare Institutional Review Board and was determined not to meet the definition of Human Subjects Research. |
|
| Reprints not available from the authors. |
© 2020
Publié par Elsevier Masson SAS.
Vol 84 - N° 2
P. 505-507 - février 2021 Retour au numéro
Article précédent
- Melanoma incidence and survival in patients with myelodysplastic syndrome: A matched cohort population-based study
- Paola Barriera-Silvestrini, David D. Xiong, Steven Lewis, Thomas Knackstedt
- Chilblain-like lesions and COVID-19 infection: A prospective observational study at Spain's ground zero
- Marta Feito-Rodríguez, Ander Mayor-Ibarguren, Carmen Cámara-Hijón, Dolores Montero-Vega, Guillermo Servera-Negre, Elena Ruiz-Bravo, Pilar Nozal, José Luis Rodríguez-Peralto, Ana Belén Enguita, Luz Yadira Bravo-Gallego, Marí Granados-Fernández, Celia Fernández-Alcalde, Álvaro Fernández-Heredero, Marina Alonso-Riaño, Víctor Jiménez-Yuste, Almudena Nuño-González, Raúl De Lucas-Laguna, Eduardo López-Granados, Pedro Herranz-Pinto
Bienvenue sur EM-consulte, la référence des professionnels de santé.